According to Fortune Business Insights, the global Intrauterine Devices Market size was valued at USD 4.48 billion in 2025. The market is projected to grow from USD 5.03 billion in 2026 to USD 12.55 billion by 2034, exhibiting a CAGR of 12.11% during the forecast period (2026–2034). The increasing demand for long-acting reversible contraceptives, growing awareness regarding family planning, regulatory approvals for extended device usage, and continuous product innovations are expected to drive market expansion. Furthermore, increasing investments in women's reproductive healthcare and improved accessibility to contraceptive solutions are creating significant growth opportunities worldwide.
Market Overview
The intrauterine devices industry is expanding as healthcare organizations increasingly promote effective family planning solutions. Rising awareness regarding unintended pregnancies and growing access to reproductive healthcare services are contributing to market development.
Manufacturers are focusing on improving device effectiveness, extending approved usage periods, and developing innovative contraceptive products.
For instance, in June 2024, Australia's Therapeutic Goods Administration approved the extension of Mirena's contraceptive usage duration from five years to eight years.
Such regulatory developments support consumer confidence and encourage the adoption of long-lasting contraceptive technologies.
However, high device costs, insertion expenses, and the availability of alternative contraceptive methods remain important challenges.
For detailed market insights: https://www.fortunebusinessinsights.com/intrauterine-devices-market-114775
Intrauterine Devices Market Trends
Increasing Demand for Long-Acting Reversible Contraception
One of the major trends influencing the intrauterine devices market is the growing preference for long-term contraceptive solutions. IUDs provide extended pregnancy prevention while remaining reversible, making them an important option in family planning programs.
Growing Focus on Hormone-Free Contraceptives
Manufacturers are increasingly developing non-hormonal intrauterine devices to expand contraceptive choices.
In January 2025, Sebela Women's Health announced positive Phase 3 clinical study results for its investigational Copper 175mm² IUD, demonstrating its efficacy, safety, and tolerability during the first three years of use.
Advancements in Device Insertion Technology
Companies are introducing improved insertion systems to simplify device placement.
In September 2024, CooperSurgical introduced a single-hand inserter designed for placing the hormone-free Paragard copper IUD.
These innovations are expected to improve convenience for healthcare professionals and support market adoption.
Intrauterine Devices Market Drivers
Growing Demand for Effective Family Planning
Increasing awareness regarding reproductive health and pregnancy planning is a significant factor driving market growth.
The report identifies fertility trends and concerns surrounding unintended pregnancies as factors encouraging demand for effective, long-acting contraceptive methods.
Increasing Regulatory Approvals
Regulatory approvals for new products and extended usage periods are strengthening market expansion.
In August 2022, the U.S. FDA approved an extension of Mirena's contraceptive usage duration to eight years, supporting longer-term contraception options.
Government and Healthcare Initiatives
Government organizations and nonprofit institutions are promoting contraceptive awareness through national family planning programs.
These initiatives help improve accessibility, particularly in developing healthcare markets.
Market Restraints
Despite promising growth, high treatment costs remain a major challenge.
The report indicates that IUD devices may cost approximately USD 400–1,000, while insertion and removal procedures can involve additional expenses.
Alternative methods, including oral contraceptive pills, vaginal rings, and barrier contraceptives, also influence market competition.
Intrauterine Devices Market Segmentation
The global market is segmented based on product, device type, shape, distribution channel, and region.
By Product
The market includes two major categories:
Devices: Hormonal and non-hormonal intrauterine devices.
Accessories: Products supporting IUD placement and related procedures.
The devices segment is expected to register strong growth due to increasing regulatory approvals and product innovations.
By Device Type
The market is classified into:
Hormonal intrauterine devices
Non-hormonal intrauterine devices, including copper, silver, and gold IUDs
By Shape
IUDs are categorized into T-shaped, U-shaped, Y-shaped, and spherical designs.
These product variations expand the range of contraceptive solutions available to healthcare providers.
By Distribution Channel
The market includes hospital pharmacies, drug stores and retail pharmacies, and other channels.
Hospital pharmacies are projected to dominate the market during the forecast period due to increasing contraceptive device distribution through healthcare facilities and government-supported hospitals.
Key Players in the Intrauterine Devices Market
Major companies operating in the global market include:
Bayer AG
CooperSurgical, Inc.
Pregna International Limited
SMB Corporation of India
AbbVie Inc.
DKT International
Mona Lisa N.V.
OCON Medical Ltd.
Prosan International BV
These companies focus on product development, regulatory approvals, distribution expansion, and technological advancements to strengthen their competitive positions.
Regional Analysis
North America
North America held the dominant share of the global intrauterine devices market in 2024.
The region benefits from regulatory approvals, established healthcare infrastructure, and the availability of advanced contraceptive technologies.
In February 2025, the U.S. FDA approved Sebela Women's Health's MIUDELLA copper intrauterine system for pregnancy prevention for up to three years.
Europe
Europe is expected to experience moderate market growth, supported by government initiatives promoting reproductive healthcare and family planning awareness.
Programs such as the European Contraception Policy Atlas contribute to improving awareness of contraceptive accessibility.
Asia Pacific
Asia Pacific is anticipated to witness considerable growth during the forecast period.
Increasing product launches and expanding availability of contraceptive devices are supporting regional market development.
Latin America
Latin America represents an important regional market, with Brazil and Mexico included in the report's geographic coverage.
Middle East & Africa
The Middle East & Africa market includes South Africa, GCC countries, and other regional economies. Family planning initiatives and improved access to contraception represent potential opportunities for market development.
Competitive Landscape
The intrauterine devices market features established pharmaceutical companies and specialized medical device manufacturers competing through innovation, product differentiation, and regulatory approvals.
Companies are investing in clinical research to develop longer-lasting and hormone-free contraceptive technologies.
Strategic partnerships and product launches are also supporting geographic expansion.
For example, Medicines360, Population Services International, and the Society for Family Health launched the Avibela levonorgestrel-releasing intrauterine system in Nigeria in March 2022.
Such developments demonstrate the industry's focus on expanding contraceptive accessibility across different healthcare markets.
Future Outlook
The global intrauterine devices market is expected to maintain strong growth through 2034.
Increasing demand for long-acting contraception, improved device designs, and greater awareness of reproductive healthcare will remain important growth factors.
Future opportunities include the development of innovative hormone-free devices, improved insertion techniques, and expanded distribution networks.
Manufacturers focusing on clinical research, regulatory compliance, and product accessibility are expected to benefit from emerging market opportunities.
Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/intrauterine-devices-market-114775
Conclusion
The global intrauterine devices market is positioned for substantial expansion, supported by growing contraceptive awareness, technological advancements, and favorable regulatory developments.
With the market projected to reach USD 12.55 billion by 2034, manufacturers and healthcare organizations have significant opportunities to improve reproductive healthcare accessibility.
Although high costs and alternative contraceptive options present challenges, continuous innovation and government-supported family planning initiatives are expected to strengthen long-term industry growth.
Latest 5 Trending FAQs
1. How big is the global intrauterine devices market?
According to Fortune Business Insights, the global intrauterine devices market was valued at USD 4.48 billion in 2025 and is projected to reach USD 12.55 billion by 2034.
2. What is the expected CAGR of the intrauterine devices market during 2026–2034?
The global intrauterine devices market is projected to grow at a CAGR of 12.11% during the forecast period from 2026 to 2034.
3. Which distribution channel is expected to dominate the intrauterine devices market?
The hospital pharmacy segment is projected to dominate due to increasing contraceptive device distribution through hospitals and government-supported healthcare facilities.
4. Who are the leading players in the intrauterine devices market?
Major companies include Bayer AG, CooperSurgical, Inc., Pregna International Limited, AbbVie Inc., SMB Corporation of India, and OCON Medical Ltd.
5. What are the major trends driving the intrauterine devices market?
Major trends include increasing demand for long-acting reversible contraceptives, development of hormone-free IUDs, regulatory approvals for extended device usage, advancements in insertion technology, and growing family planning awareness.
What’s Driving Japan’s Market? Discover the Latest Intrauterine Devices Market Insights